Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells

Journal of Molecular and Cellular Cardiology

Volumn 56, Issue 1, 2013, Pages 1-7

  Jiang, Qin ^a   Song, Peng ^b   Wang, Enshi ^a   Li, Jun ^a   Hu, Shengshou ^a   Zhang, Hao ^a  

^a FUWAI HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cell biology; Cell transplantation; Mesenchymal stromal cells; Myocardial infarction; Remote ischemic postconditioning

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GENOMIC DNA; POLYCLONAL ANTIBODY; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE RELEASE; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE INJURY; IMMUNOHISTOCHEMISTRY; ISCHEMIC POSTCONDITIONING; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REMOTE ISCHEMIC POSTCONDITIONING; TRANSCRIPTION REGULATION; Y CHROMOSOME;

ADMINISTRATION, INTRAVENOUS; ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL12; CORONARY VESSELS; FEMALE; GENETIC MARKERS; HEART VENTRICLES; ISCHEMIC POSTCONDITIONING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SEX-DETERMINING REGION Y PROTEIN; STROKE VOLUME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84872811485     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.12.016     Document Type: Article

References (33)

1. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277-2286.
2. Chavakis E., Koyanagi M., Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 2010, 21:325-335.
3. Wang W., Jiang Q., Zhang H., Jin P., Yuan X., Wei Y., et al. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen Med 2011, 6:179-190.
4. Hausenloy D.J., Yellon D.M. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 2011, 8:619-629.
5. Weber C. Far from the heart: receptor cross-talk in remote conditioning. Nat Med 2011, 16:760-762.
6. Kamota T., Li T.S., Morikage N., Murakami M., Ohshima M., Kubo M., et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 2009, 53:1814-1822.
7. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
8. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 2003, 362:697-703.
9. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
10. Zhang H., Zhu S.J., Wang W., Wei Y.J., Hu S.S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther 2008, 15:40-48.
11. Wang J., Huang W., Wu Y., Hou J., Nie Y., Gu H., et al. MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5. Stem Cells Dev 2012, 21:2508-2519.
12. Wang W., Jin P., Wang L., Yang Z., Hu S., Gao B., et al. Impact of escaped bone marrow mesenchymal stromal cells on extracardiac organs after intramyocardial implantation in a rat myocardial infarction model. Cell Transplant 2010, 19:1599-1607.
13. Zhang H., Song P., Tang Y., Zhang X.L., Zhao S.H., Wei Y.J., et al. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J Thorac Cardiovasc Surg 2007, 134:1234-1240.
14. Zhang H., Yuan X., Jin P.F., Hou J.F., Wang W., Wei Y.J., et al. Alteration of parasympathetic/sympathetic ratio in the infarcted myocardium after Schwann cell transplantation modified electrophysiological function of heart: a novel antiarrhythmic therapy. Circulation 2010, 122:S193-S200.
15. Zhang H., Chen H., Wang W., Wei Y.J., Hu S.S. Cell survival and redistribution after transplantation into damaged myocardium. J Cell Mol Med 2010, 14:1078-1082.
16. Cheung M.M., Kharbanda R.K., Konstantinov I.E., Shimizu M., Frndova H., Li J., et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006, 47:2277-2282.
17. Hausenloy D.J., Mwamure P.K., Venugopal V., Harris J., Barnard M., Grundy E., et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. Lancet 2007, 370:575-579.
18. Hoole S.P., Heck P.M., Sharples L., Khan S.N., Duehmke R., Densem C.G., et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation 2009, 119:820-827.
19. Bøtker H.E., Kharbanda R., Schmidt M.R., Bøttcher M., Kaltoft A.K., Terkelsen C.J., et al. Remote ischemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomized trial. Lancet 2010, 375:727-734.
20. Ozeke O., Gungor M., Ozer C. Is remote ischemic preconditioning triggered by intermittent claudication secondary to peripheral arterial disease responsible for preventing early mortality after coronary artery bypass surgery?. Ann Thorac Surg 2011, 91:333-334.
21. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008, 88:581-609.
22. Tang X.L., Qiu Y., Park S.W., Sun J.Z., Kalya A., Bolli R. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 1996, 79:424-434.
23. Tang Y.L., Zhu W., Cheng M., Chen L., Zhang J., Sun T., et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009, 104:1209-1216.
24. Ghadge S.K., Mühlstedt S., Ozcelik C., Bader M. SDF-1 alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 2011, 129:97-108.
25. Zaruba M.M., Theiss H.D., Vallaster M., Mehl U., Brunner S., David R. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009, 4:313-323.
26. Haider H.K., Jiang S., Idris N.M., Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 2008, 103:1300-1308.
27. Elmadbouh I., Haider H.K., Jiang S., Idris N.M., Lu G., Ashraf M. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007, 42:792-803.
28. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
29. Segers V.F., Tokunou T., Higgins L.J., MacGillivray C., Gannon J., Lee R.T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116:1683-1692.
30. Murakami J., Li T.S., Ueda K., Tanaka T., Hamano K. Inhibition of accelerated tumor growth by blocking the recruitment of mobilized endothelial progenitor cells after chemotherapy. Int J Cancer 2009, 124:1685-1692.
31. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
32. Fang J., Chen L., Fan L., Wu L., Chen X., Li W., et al. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats. J Mol Cell Cardiol 2011, 51:839-847.
33. Wei M., Xin P., Li S., Tao J., Li Y., Li J., et al. Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction. Circ Res 2011, 108:1220-1225.